ATON logo
ATON NASDAQ VG

AlphaTON Capital Corp. - Common Stock

Healthcare · Biotechnology Website · IPO Oct 2013
$0.32
▼ $-0.01 (-2.77%)
Vol 568K
4
Quality Score
fail
Mkt Cap
$4.6M
ROE
-674.0%
D/E
2.00
Beta
2.49
52W
$1–$14

Wall Street Consensus

6 analysts · Oct 2024
0
Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating

Price Chart

Earnings

Beat rate: 25.0%
Quarter EPS Est EPS Act Surprise
Jun 2025 $-1.26
Dec 2023 $-5.51 $0.20 +$5.71
Jun 2023 $-4.90 $-6.60 $-1.70
Mar 2023 $-110.77 $-117.20 $-6.43

Fundamentals Trend

Metric 2024-09-30 2025-03-31 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -674.0% -674.0% -674.0% -674.0% -674.0%
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio 2.00 2.00 2.00 2.00 2.00
Current Ratio 3.08 2.02 2.02 2.02 2.02 2.02

Key Ratios

ROA (TTM)
-288.6%
EPS (TTM)
$-8.56
52W High
$13.80
52W Low
$0.64
$0.64 52-Week Range $13.80

How does ATON compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

ATON AAPG ABEO ABOS ABP

ATON valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
0% below peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

ATON profitability vs Biotechnology peers

ROE
-674.0%
901% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-288.6%
518% below peers (-46.7%)
vs Peers
vs Industry
Weak

ATON financial health vs Biotechnology peers

D/E ratio
2.0
0% below peers (0.0)
vs Peers
vs Industry
In line
Current ratio
2.0
54% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
2.5
156% above peers (1.0)
vs Peers
vs Industry
More volatile

ATON fundamentals radar

ATON Peer median Industry

ATON profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

ATON vs peers: key metrics